Type to search

Gilead Sciences Completes Acquisition of MiroBio | Pharmtech Focus
Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in the TROPiCS-02 Study | Pharmtech Focus
Gilead Sciences to Acquire MiroBio | Pharmtech Focus